Clinical Trial: RE104 Clinical Lactation Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Lactation
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Single Dose Study to Evaluate the Concentration of RE104 and Its Major Metabolites in Breast Milk and Plasma of Healthy Lactating Women.
Brief Summary:
The purpose of this study is to obtain data necessary to characterize the elimination of RE104 and metabolites from breastmilk of health lactating volunteers to support a regulatory assessment of when mothers can safely return to breastfeeding following a single-dose of RE104 for Injection.
Read more